Furthermore, increased expression of TREM2 resulted in both reduction of M1 microglia, which contribute to AD pathogenesis by inducing pro-inflammatory responses and neuronal damage [77], and increase of M2 microglia, which ameliorate AD pathology through release of anti-inflammatory cytokines and neurotropic factors [78]. The gene discussed is TREM2; the disease is Alzheimer disease.